Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87 ...

Patients with stage III melanoma were treated with nivolumab (anti-PD1) and relatlimab (anti-LAG-3) before surgery87% of ...

Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors , nivolumab and relatlimab ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and ...

A genetically modified herpes virus, also known as RP1, could soon be getting the green light to be approved by US and ...

I-Mab (NASDAQ:IMAB) is one of the best-performing NASDAQ stocks according to analysts. On July 2, I-Mab announced the presentation of positive Phase 1b combination data for givastomig at the European ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

Patients were treated with a genetically modified HSV-1 in combination with an immunotherapy (nivolumab). By the end of the ...

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated tumors.

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...